LobbyingIntuitive Surgical lobbying by quarter
Intuitive Surgical ISRG's latest lobbying report covers Q2 2026, at $170K. The four quarters Q3 2025–Q2 2026 total $780K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Intuitive SurgicalISRG
- Latest quarter
- $170K
- Q2 2026 · 2 reports
- Last 12 months
- $780K
- Last 4 quarters
- vs last quarter
- −15.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $90K | 2 |
| Q1 2023 | $310K | 2 |
| Q2 2023 | $90K | 2 |
| Q3 2023 | $120K | 2 |
| Q4 2023 | $140K | 2 |
| Q1 2024 | $90K | 2 |
| Q2 2024 | $100K | 2 |
| Q3 2024 | $100K | 2 |
| Q4 2024 | $150K | 2 |
| Q1 2025 | $110K | 2 |
| Q2 2025 | $190K | 2 |
| Q3 2025 | $240K | 2 |
| Q4 2025 | $170K | 2 |
| Q1 2026 | $200K | 2 |
| Q2 2026 | $170K | 2 |
Policy issues the reports name
- Health issues30 reports
- Medical research and clinical labs15 reports
- Trade8 reports
- Tariffs5 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES19 reports
- SENATE18 reports
- U.S. Trade Representative (USTR)2 reports
- Commerce, Dept of (DOC)1 reports
- Intl Trade Administration (ITA)1 reports
- Treasury, Dept of1 reports
- U.S. International Trade Commission (ITC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseIntuitive Surgical | $1.8M | 15 quarters |
| FGS Global | $470K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $130K |
| 07/16for Q2 | FGS Global | $40K |
| 04/20for Q1 | In-house | $160K |
| 04/13for Q1 | FGS Global | $40K |
| 01/20for Q4 2025 | In-house | $130K |
| 01/14for Q4 2025 | FGS Global | $40K |
| 25/10/22for Q3 2025 | In-house | $200K |
| 25/10/20for Q3 2025 | In-house | $170K |
| 25/10/14for Q3 2025 | FGS Global | $40K |
| 25/07/21for Q2 2025 | In-house | $150K |
| 25/07/16for Q2 2025 | FGS Global | $40K |
| 25/04/21for Q1 2025 | In-house | $80K |
| 25/04/15for Q1 2025 | FGS Global | $30K |
| 25/01/21for Q4 2024 | In-house | $120K |
| 25/01/14for Q4 2024 | FGS Global | $30K |
| 24/10/21for Q3 2024 | In-house | $70K |
| 24/10/16for Q3 2024 | FGS Global | $30K |
| 24/07/22for Q2 2024 | In-house | $70K |
| 24/07/16for Q2 2024 | FGS Global | $30K |
| 24/04/19for Q1 2024 | In-house | $70K |